Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Firefly Neuroscience (AIFF) Depreciation & Amortization (CF) (2016 - 2025)

Firefly Neuroscience has reported Depreciation & Amortization (CF) over the past 15 years, most recently at $52000.0 for Q4 2025.

  • Quarterly results put Depreciation & Amortization (CF) at $52000.0 for Q4 2025, down 11.86% from a year ago — trailing twelve months through Dec 2025 was $172000.0 (up 156.72% YoY), and the annual figure for FY2025 was $172000.0, up 156.72%.
  • Depreciation & Amortization (CF) for Q4 2025 was $52000.0 at Firefly Neuroscience, down from $58000.0 in the prior quarter.
  • Over the last five years, Depreciation & Amortization (CF) for AIFF hit a ceiling of $125475.0 in Q4 2021 and a floor of -$164471.0 in Q4 2023.
  • Median Depreciation & Amortization (CF) over the past 5 years was $53669.0 (2023), compared with a mean of $36609.7.
  • Biggest five-year swings in Depreciation & Amortization (CF): surged 2810.82% in 2021 and later tumbled 403.36% in 2023.
  • Firefly Neuroscience's Depreciation & Amortization (CF) stood at $125475.0 in 2021, then plummeted by 56.79% to $54216.0 in 2022, then tumbled by 403.36% to -$164471.0 in 2023, then surged by 135.87% to $59000.0 in 2024, then dropped by 11.86% to $52000.0 in 2025.
  • The last three reported values for Depreciation & Amortization (CF) were $52000.0 (Q4 2025), $58000.0 (Q3 2025), and $43000.0 (Q2 2025) per Business Quant data.